Tuesday 24 August 2021
A nationwide study by a medical student, Joyce Guo, and researchers from the Pharmacoepidemiology Research Network has found that real-world type 2 diabetes treatment patterns are complex and not always consistent with guidelines.
Friday 13 August 2021
People using two different inhalers for common chronic lung diseases are more than 50 per cent more likely to have a heart attack than those on just one, new University of Otago-led research reveals.
Thursday 5 August 2021
Groups who suffer the highest burden of type 2 diabetes have the lowest level of adherence to effective medication to control it, a University of Otago study has found.
Wednesday 28 July 2021
Associate Professor Lianne Parkin and colleagues from the Pharmacoepidemiology Research Network have been awarded $1.2 million from the Health Research Council of New Zealand to investigate the use and safety of an anti-nausea drug during pregnancy.
Tuesday 8 June 2021
University of Otago research into what helps and hinders people with type 2 diabetes correctly taking, and continuing to take, metformin, features in today’s New Zealand Medical Journal.
Wednesday 19 May 2021
Almost half of New Zealand women who take antidepressants in the months before getting pregnant, stop during their pregnancy, a new University of Otago study shows.
Tuesday 9 February 2021
The Ngāi Tahu Māori Health Research Unit's Dr Karyn Maclennan is currently piloting a new, innovative and hands-on education programme targeted at tamariki.
Wednesday 27 January 2021
The use of two long-acting bronchodilator inhalers to treat chronic obstructive pulmonary disease (COPD) symptoms is associated with a higher risk of acute coronary syndrome (ACS, heart attack or unstable angina) than the use of just one long-acting bronchodilator according to recently published research by investigators from the Pharmacoepidemiology Research Network at the University of Otago.